In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $34.04 in the prior trading day, RAPT Therapeutics Inc (NASDAQ: RAPT) closed at $33.81, down -0.68%. In other words, the price has decreased by -$0.68 from its previous closing price. On the day, 1.71 million shares were traded. RAPT stock price reached its highest trading level at $35.59 during the session, while it also had its lowest trading level at $33.445.
Ratios:
Our goal is to gain a better understanding of RAPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.04 and its Current Ratio is at 12.04. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Guggenheim on October 27, 2025, initiated with a Buy rating and assigned the stock a target price of $70. On October 20, 2025, JP Morgan Upgraded its rating to Overweight which previously was Neutral but kept the price unchanged to $55. On October 13, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $35.Barclays initiated its Overweight rating on October 13, 2025, with a $35 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RAPT now has a Market Capitalization of 936904640 and an Enterprise Value of 782156544.
Stock Price History:
The Beta on a monthly basis for RAPT is 0.46, which has changed by 1.4288793 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, RAPT has reached a high of $42.39, while it has fallen to a 52-week low of $5.67. The 50-Day Moving Average of the stock is 10.02%, while the 200-Day Moving Average is calculated to be 109.93%.
Shares Statistics:
The stock has traded on average 492.14K shares per day over the past 3-months and 508530 shares per day over the last 10 days, according to various share statistics. A total of 27.71M shares are outstanding, with a floating share count of 17.87M. Insiders hold about 35.50% of the company’s shares, while institutions hold 30.07% stake in the company. Shares short for RAPT as of 1764288000 were 1004353 with a Short Ratio of 2.04, compared to 1761868800 on 1060011. Therefore, it implies a Short% of Shares Outstanding of 1004353 and a Short% of Float of 4.04.
Earnings Estimates
A detailed examination of RAPT Therapeutics Inc (RAPT) is currently in progress, with 7.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.66, with high estimates of -$0.43 and low estimates of -$0.95.
Analysts are recommending an EPS of between -$0.99 and -$2.95 for the fiscal current year, implying an average EPS of -$2.48. EPS for the following year is -$3.13, with 7.0 analysts recommending between -$1.77 and -$4.27.
